Fenwick IP Duo Receive Distinguished Legal Writing Award forAI& Drug Discovery Article
Related Industries.AI& Machine Learning. Share twitter logo. Subscribe. Related Insights. Publications Emerging Legal Terrain: IPRisksfrom AI's …
Fenwick 17
Covers: AI Agents & AutomationBanking & FinanceLegal & CourtsHealthcareGovernance & Risk ManagementCybersecurityManufacturing & RoboticsChatbots & LLMsMarkets & InvestmentRegulation & Policy
AI in the Insurance Industry: Balancing Innovation and Governance in 2025 - Fenwick
Insurers working with Fire Break Riskcan access its model and data to identify homes with lowriskand strong mitigation measures and offer discounts …
CLE Takeaways: Top 10 Privacy & Cybersecurity Must-Knows for 2025 - Fenwick
...AI may be able to produce with accurate representations of their AI capabilities.Risksassociated with the use of AI must be accurately disclosed …
The Rise (and Risks) of AI Agents in Crypto | Fenwick
An AI agent is a computer program that uses AI to perform tasks based on the tools made available to it (e.g., integrations with third-party services) …
The Rise (and Risks) ofAIAgents in Crypto | Fenwick
Performing appropriateriskassessments before AI agent-based services are launched is crucial to avoid running afoul of consumer protection …
What Startups and Big Pharma Need to Know AboutAIDrug Discovery - Fenwick
For large pharmaceutical companies, the benefits of AI tools in drug discovery often outweigh the IPrisks, but thoserisksmust still be managed …
FDA Issues Draft Guidances on AI in Medical Devices, Drug Development - Fenwick
The guidances emphasize the need for comprehensive AI policies addressingriskevaluation, data management, transparency, validation, and …
What is the IP Risk Profile in AI Drug Discovery? | Fenwick
For example, a company that uses AI to predict molecule candidates, then uses robots to do the wet labs to test the candidates may carry more risk …
What is the IPRisk Profile inAIDrug Discovery? | Fenwick
The scientific benefits and legalrisksofAI-driven drug discovery are consequential. But recent IP law decisions allude to a general concept …
AI& Drug Discovery: Key Patent Considerations - Fenwick
...Risksfrom AI'sRole in Drug Discovery. Key takeaways:AI alone can't qualify as an inventor—human contribution remains essential. In drug discovery, …
Don't Wait for the DOJ to Come Knocking: Important Whistleblower… - Fenwick
...AI Risk Management Updates ... The key takeaway from this is that DOJ expects companies to identify emerging risks derived from “new technologies,” …
FTC Outlines Five Don'ts forAIChatbots | Fenwick
...risksassociated with AI chatbots. Suchriskassessment and mitigation include taking steps to ensure that the AI chatbot does not generate …
BalancingAI-Powered Drug Discovery'sRiskand Reward | Fenwick
BalancingAI-Powered Drug Discovery'sRiskand Reward. What You Need To Know. Patenting drugs discovered with AI assistance requires …
UnpackingAI-Assisted Drug Discovery Patents - Fenwick & West LLP
Specialized AI carries rewards—and potentialrisks. Building a specialized AI that's designed to help find solutions for a specific problem can …
Evaluating AI Risks: What Companies Need to Know | Fenwick
From a technical perspective,AI models have inherent uncertainties due to their probabilistic nature. Even highly accurate systems will sometimes …
Evaluating AI Risk: What Every Company Needs to Know | Fenwick
& West LLPNot allartificial intelligence(AI) is created equal. However, what are the emergingrisksand questions companies should be asking about AI to …
Best Practices for UtilizingAI/ML Tools as NAIC… | Fenwick & West LLP
The Model Bulletin urges insurers to mitigateAI-relatedrisks, such as discrimination, data vulnerability and lack of transparency. This guidance …